10 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... in CKD + T2DM; ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... #CVD #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Angina, HFpEF, ... HFrEF, AFib, TAA ... Dissection • CKD ... #management
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... Chronotropes • Medications ... used in HFrEF: ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... failure; HFpEF, ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... #HeartFailure #HFrEF ... #Pharmacology #Management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... outcomes in CKD ... #table #comparison ... #management #endocrinology
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
Blood Pressure Management ... Amlodipine • HFrEF ... BloodPressure #medications ... #pharmacology #table ... #agents #internship
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pharmacologic Pain Management ... adults, <3g in CKD ... avoid NSAIDs if CKD ... • Neuropathic agents ... #Ladder #medications
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... guidelines for CAD ... and HFpEF* 2. ... Enroll in HFpEF ... #CAD #Management
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
antihypertensive agents ... with previously stable ... or papilledema, heart ... parenchymal disease: CKD ... Differential #Diagnosis #indications